News · 26 weeks31-75%
2025-12-142026-06-07
Mix1990d
- SEC Filings8(42%)
- Insider6(32%)
- Other3(16%)
- Earnings2(11%)
Latest news
25 items- SECOrthoPediatrics Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- PROrthoPediatrics to Participate in the Goldman Sachs 47th Annual Global Healthcare ConferenceWARSAW, Ind., May 26, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Fred Hite, Chief Operating Officer, and Chief Financial Officer, is scheduled to participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference, held in Miami Beach, FL. Event: Goldman Sachs 47th Annual Global Healthcare Conference 2026Format: Fireside ChatDate: Monday, June 8, 2026Time: 2:40 pm ET An audio webcast of the discussion will be available online at the OrthoPediatrics' investor relations website, http://ir.orthopediatrics.com. Ad
- INSIDERGeneral Counsel and Secretary Gerritzen Daniel J gifted 2,479 shares, decreasing direct ownership by 2% to 147,054 units (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- SECSEC Form 10-Q filed by OrthoPediatrics Corp.10-Q - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- SECOrthoPediatrics Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- SECOrthoPediatrics Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- PROrthoPediatrics Corp. Reports First Quarter 2026 Financial Results and Increases 2026 Financial GuidanceWARSAW, Ind., April 30, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the first quarter ended March 31, 2026. First Quarter 2026 and Business Highlights Helped a record of over 45,000 children in the first quarter of 2026Generated total revenue of $59.4 million for the first quarter of 2026, up 13% from $52.4 million in the first quarter of 2025; domestic revenue increased 11% and international revenue increased 22% in the quarterGrew worldwide Trauma & Deformity revenue 14% and worldwide Scoliosis revenue 13% in
- PROrthoPediatrics Expands Specialty Bracing Portfolio with TRAXIO Halo Gravity Traction SystemWARSAW, Ind., April 30, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing ("OPSB") portfolio with a new product launch, the TRAXIO Complete - Weight System, in collaboration with Synetik Group, Inc. The Halo Gravity Traction system was designed to deliver controlled, weight-based axial traction for gradual spinal realignment in infants, children, and adolescents for Children's hospitals to advance their standard of pediatric spine care. TRAXIO is a non-active, mechanical traction system that u
- SECSEC Form DEF 14A filed by OrthoPediatrics Corp.DEF 14A - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- SECSEC Form DEFA14A filed by OrthoPediatrics Corp.DEFA14A - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- PROrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026WARSAW, Ind., April 16, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2026 financial results on Thursday, April 30, 2026 after the market closes. OrthoPediatrics will host a conference call on Thursday, April 30, 2026 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be av
- SECOrthoPediatrics Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- PROrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare ConferenceWARSAW, Ind., March 31, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference. Event: 25th Annual Needham Virtual Healthcare Conference Format: Fireside ChatDate: Tuesday, April 14, 2026Time: 9:30 am ET An audio webcast of the discussions will be available online at the OrthoPediatrics' investor relations website, http://ir.o
- INSIDERCOO and CFO Hite Fred was granted 77,405 shares and sold $224,129 worth of shares (12,993 units at $17.25), increasing direct ownership by 30% to 277,477 units (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERPres. Trauma & Def. Correction Hauser Joseph W was granted 65,700 shares and sold $148,281 worth of shares (8,596 units at $17.25), increasing direct ownership by 41% to 194,767 units (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERPresident and CEO Bailey David R sold $336,979 worth of shares (19,535 units at $17.25), decreasing direct ownership by 6% to 298,020 units (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERPresident of Scoliosis Odle Gregory A sold $145,469 worth of shares (8,433 units at $17.25) and was granted 47,380 shares, increasing direct ownership by 26% to 187,735 units (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERGeneral Counsel and Secretary Gerritzen Daniel J was granted 47,380 shares and sold $148,592 worth of shares (8,614 units at $17.25), increasing direct ownership by 35% to 149,533 units (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- SECSEC Form 144 filed by OrthoPediatrics Corp.144 - ORTHOPEDIATRICS CORP (0001425450) (Subject)
- SECSEC Form 10-K filed by OrthoPediatrics Corp.10-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- PROrthoPediatrics to Participate in Upcoming ConferencesWARSAW, Ind., Feb. 27, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in two upcoming investor conferences. Event: TD Cowen 46th Annual Health Care Conference Format: Fireside Chat Date: Tuesday, March 3, 2026Time: 1:10 pm ET Event: The Citizens Life Sciences Conference Format: Fireside Chat Date: Tuesday, March 10, 2026Time: 10:10 am ET An audio webcast of the discussions will be available online at the OrthoPediatrics' investor relations website, http://ir.orthopediatrics.com. Additionally, a replay will be availabl
- SECOrthoPediatrics Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- SECOrthoPediatrics Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- PROrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2025 Financial ResultsRecord full year 2025 revenue of $236.3 million increased 15% compared to prior yearOperating Cash flow improvement of $22 million in full year 2025Generated $10 million of free cash flow in the fourth quarter, the first quarter of positive free cash flow in Company history WARSAW, Ind., Feb. 26, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Highlights Helped over 37,500 children in the fourth quarter 2025 and approximately
- PROrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026WARSAW, Ind., Feb. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes. OrthoPediatrics will host a conference call on Thursday, February 26, 2026 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. Th
KIDS FAQ
7 questionsWhat does OrthoPediatrics Corp. do?
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica...Where does KIDS stock trade?
OrthoPediatrics Corp. (KIDS) is listed on NASDAQ.What sector and industry is KIDS in?
OrthoPediatrics Corp. operates in the Health Care sector, Medical/Dental Instruments industry.When did OrthoPediatrics Corp. go public?
OrthoPediatrics Corp. (KIDS) completed its IPO in 2017.What are analysts saying about KIDS?
OrthoPediatrics Corp. has had 8 recent analyst actions on file. The most recent action was from TD Cowen: Buy with a $2300.00 price target on 2026-01-27. Recent price targets range from $2300.00 to $3700.00.What companies are similar to KIDS?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare KIDS side-by-side with any of them on Quantisnow.How can I track KIDS on Quantisnow?
Quantisnow aggregates OrthoPediatrics Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow KIDS to receive live email and push alerts on every new disclosure.